Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urologic Diseases » Kidney Diseases » Renal Insufficiency
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Kidney Diseases » Renal Insufficiency
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Kidney Diseases » Renal Insufficiency
Description
Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE. MeSH
Hierarchy View
Subtype Terms (3)
Acute Kidney Injury
175 drugs (112 approved, 63 experimental)
Cardio-Renal Syndrome
19 drugs (16 approved, 3 experimental)
Renal Insufficiency, Chronic
383 drugs (206 approved, 177 experimental)
Approved Indicated Drugs (3)
Phase 3 Indicated Drugs (23)
Phase 2 Indicated Drugs (27)
Phase 1 Indicated Drugs (68)
Other Experimental Indicated Drugs (21)
Organization Involved with Phase 4 Indications (216)
Ahvaz Jundishapur University of Medical Sciences
Catholic University of Sacred Heart, Rome
Centre Georges Francois Leclerc
Centre Hospitalier Departemental Vendee
Centro Medico Lic Adolfo Lopez Mate
Coney Island Hospital, Brooklyn, NY
Daewon Pharmaceutical Co., Ltd.
Hamadan University of Medical Science
Hoosier Cancer Research Network
Hospital General de México Dr. Eduardo Liceaga
Hospital General Universitario Gregorio Marañon
Huazhong University of Science and Technology
Institute for Health Outcomes and Process Evaluation Reseach
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Instituto Nacional de la Nutrición Salvador Zubiran
Memorial University of Newfoundland
Molecular Physiological Chemistry Laboratory, Inc.
NephroNet Clinical Research Consortium
New York Presbyterian Hospital
Oregon Health and Science University
People's Liberation Army of China
Southeast Renal Research Institute
Spanish Clinical Research Network
Technical University of Munich
University of California, Davis
University of Colorado, Denver
University of Las Palmas de Gran Canaria
University of Naples Frederico II
University of Picardie Jules Verne
University of Roma La Sapienza
Virginia Commonwealth University
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 3 Indications (136)
Anandabawa Kidney Dialysis Center, Jamnagar
Apollo Hospitals, Chennai, India
Aspirus Heart and Vascular Institute-Research and Education
Bambino Gesù Hospital and Research Institute
Beijing Biostats Technology Co. Ltd.
Beijing Heyiyuan Biotech Co. Ltd.
California Institute of Renal Research, Inc.
Centre Hospitalier Universitaire de Nīmes
French National Agency for Research on AIDS and Viral Hepatitis
General Hospital of Chinese Armed Police Forces
German Federal Ministry of Education and Research
Gujarat Kidney Foundation, Ahmedabad
Hamilton Health Sciences Corporation
Heart and Stroke Foundation of Canada
IKDRC, Civil Hospital, Ahmedabad
Institut d'Anesthesiologie des Alpes Maritimes
Instituto Mexicano del Seguro Social
Instituto Nacional de Cardiologia Ignacio Chavez
Laboratório Químico Farmacêutico Bergamo Ltda.
LAL Clinical Reseach e Development Ltda
Medley Pharmaceutical Industry SA
National Hepatology & Tropical Medicine Research Institute
National Hospital Organization Osaka National Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
Onassis Cardiac Surgery Centre
Region Hospital Fredericia, Denmark
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Swiss National Science Foundation
Organization Involved with Phase 2 Indications (104)
Anhui College of Traditional Chinese Medicine
Clinical Pharmacology of Miami
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Cooperative Clinical Trials in Pediatric Transplantation
Fundação de Amparo à Pesquisa do Estado de São Paulo
Hospital Universitario Ramon y Cajal
Institut National de la Santé Et de la Recherche Médicale, France
Medical University of South Carolina
Methodist Cancer Center, Houston, Texas
National Center for Complementary and Integrative Health (NCCIH)
National Health Service, United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
Northeast Clinical Research Center
Pirogov Russian National Research Medical University
Pulmonary and Critical Care Assoc. of Baltimore
Pulmonary Critical Care Associates of Baltimore
Russian Academy of Medical Sciences
Russian State Medical University
Organization Involved with Phase 1 Indications (137)
American Research Corporation (ARC)
Boryung Pharmaceutical Company
Carol Davila University of Medicine and Pharmacy
Cognitive Research Corporation
Mazandaran University of Medical Sciences
National Cancer Institute (NCI)
New Orleans Center for Clinical Research
Orlando Clinical Research Center
Pharmaceutical Project Solutions, Inc.
Pharmaceutical Research Associates, Inc. (PRA)
Regenerative Medicine Minnesota
Organization Involved with Other Experimental Indications (35)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
